Found: 16
Select item for more details and to access through your institution.
Risk factors determining adherence to tyrosine kinase inhibitors in chronic myeloid leukaemia.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 5, p. 902, doi. 10.1177/10781552231196130
- By:
- Publication type:
- Article
Treatment of Chronic Lymphocytic Leukemia in the Personalized Medicine Era.
- Published in:
- Pharmaceutics, 2024, v. 16, n. 1, p. 55, doi. 10.3390/pharmaceutics16010055
- By:
- Publication type:
- Article
A Real-World Evidence-Based Study of Long-Term Tyrosine Kinase Inhibitors Dose Reduction or Discontinuation in Patients with Chronic Myeloid Leukaemia.
- Published in:
- Pharmaceutics, 2023, v. 15, n. 5, p. 1363, doi. 10.3390/pharmaceutics15051363
- By:
- Publication type:
- Article
Rational Coformer Selection in the Development of 6-Propyl-2-thiouracil Pharmaceutical Cocrystals.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 3, p. 370, doi. 10.3390/ph16030370
- By:
- Publication type:
- Article
Enhanced NSAIDs Solubility in Drug–Drug Formulations with Ciprofloxacin †.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 4, p. 3305, doi. 10.3390/ijms24043305
- By:
- Publication type:
- Article
Metformin-NSAIDs Molecular Salts: A Path towards Enhanced Oral Bioavailability and Stability.
- Published in:
- Pharmaceutics, 2023, v. 15, n. 2, p. 449, doi. 10.3390/pharmaceutics15020449
- By:
- Publication type:
- Article
New Metformin–Citric Acid Pharmaceutical Molecular Salt: Improving Metformin Physicochemical Properties.
- Published in:
- Crystals (2073-4352), 2022, v. 12, n. 12, p. 1748, doi. 10.3390/cryst12121748
- By:
- Publication type:
- Article
Impact of Genetic Polymorphisms and Biomarkers on the Effectiveness and Toxicity of Treatment of Chronic Myeloid Leukemia and Acute Myeloid Leukemia.
- Published in:
- Journal of Personalized Medicine, 2022, v. 12, n. 10, p. 1607, doi. 10.3390/jpm12101607
- By:
- Publication type:
- Article
Towards the Development of Novel Diclofenac Multicomponent Pharmaceutical Solids.
- Published in:
- Crystals (2073-4352), 2022, v. 12, n. 8, p. 1038, doi. 10.3390/cryst12081038
- By:
- Publication type:
- Article
Lidocaine Pharmaceutical Multicomponent Forms: A Story about the Role of Chloride Ions on Their Stability.
- Published in:
- Crystals (2073-4352), 2022, v. 12, n. 6, p. 798, doi. 10.3390/cryst12060798
- By:
- Publication type:
- Article
Novel Polymorphic Cocrystals of the Non-Steroidal Anti-Inflammatory Drug Niflumic Acid: Expanding the Pharmaceutical Landscape.
- Published in:
- Pharmaceutics, 2021, v. 13, n. 12, p. 2140, doi. 10.3390/pharmaceutics13122140
- By:
- Publication type:
- Article
Furosemide/Non-Steroidal Anti-Inflammatory Drug–Drug Pharmaceutical Solids: Novel Opportunities in Drug Formulation.
- Published in:
- Crystals (2073-4352), 2021, v. 11, n. 11, p. 1339, doi. 10.3390/cryst11111339
- By:
- Publication type:
- Article
Interconvertible Hydrochlorothiazide–Caffeine Multicomponent Pharmaceutical Materials: A Solvent Issue.
- Published in:
- Crystals (2073-4352), 2020, v. 10, n. 12, p. 1088, doi. 10.3390/cryst10121088
- By:
- Publication type:
- Article
FCGR2A/FCGR3A Gene Polymorphisms and Clinical Variables as Predictors of Response to Tocilizumab and Rituximab in Patients With Rheumatoid Arthritis.
- Published in:
- Journal of Clinical Pharmacology, 2019, v. 59, n. 4, p. 517, doi. 10.1002/jcph.1341
- By:
- Publication type:
- Article
Pomalidomide in the treatment of multiple myeloma: design, development and place in therapy.
- Published in:
- Drug Design, Development & Therapy, 2017, v. 11, p. 2399, doi. 10.2147/dddt.s115456
- By:
- Publication type:
- Article
Transplantation-Associated Thrombotic Microangiopathy in Patients Treated With Sirolimus and Cyclosporine as Salvage Therapy for Graft-Versus-Host Disease.
- Published in:
- Annals of Pharmacotherapy, 2015, v. 49, n. 9, p. 986, doi. 10.1177/1060028015593369
- By:
- Publication type:
- Article